Armenian CB registered new branch of Ameriabank “Dilijan”

YEREVAN, February 15. /ARKA/. Armenian Central bank registered new branch of CJSC “Ameriabank” “Dilijan”. Such a decision was made on February 15, 2010 by Artur Javadyan, Chairman of Central Bank.

CJSC “Ameriabank”(former “Armimpexbank” renamed in May 2008) was founded in July 1992 on the basis of Armenian branch of Vnesheconombank of USSR. On September 8, 1992 it got license of CB Armenia for banking activity. In August 2007 the shares of the bank were obtained by “T-D-A Holding Limited” affiliated by leading and largest Russian investment-banking company – the group “Troyka Dialog”.

From November 3, 2008 Open JSC “Armenian Stock Exchange” awarded CJSC “Ameriabank” the status of market-maker of bonds of “IMPEX Group” Ltd.

There were 3 operating branches of the bank as of December 31, 2009. ($1-381.12 drams).—0—

spot_img

POPULAR

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img